These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6158827)

  • 41. [Changes in plasma coagulant factors and plasma fibrinolytic activity in patients with viral hepatitis].
    Wang H
    Zhonghua Yi Xue Za Zhi; 1991 Nov; 71(11):608-11, 42. PubMed ID: 1666971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
    Grimaudo V; Omri A; Kruithof EK; Hauert J; Bachmann F
    Thromb Haemost; 1988 Jun; 59(3):388-91. PubMed ID: 2847348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hematological disorders in patients with gastric cancer].
    Yamamura T
    Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):675-85. PubMed ID: 6493191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The values of plasminogen, antithrombin III, factor XIII and fibrinogen according to age and sex].
    Ogawa K; Baba S; Funazaki K; Nakanishi K; Hirohashi K; Suzuki E; Tamura M
    Rinsho Byori; 1984 Jun; 32(6):679-82. PubMed ID: 6436556
    [No Abstract]   [Full Text] [Related]  

  • 46. Alterations of clotting factors and platelets during hemofiltration.
    Köstering H; Girndt J; Matthaei D; Naidu R; Quellhorst E
    J Dial; 1977; 1(6):607-17. PubMed ID: 75895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet and coagulation factors in proliferative diabetic retinopathy.
    Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
    J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of high-dose medroxyprogesterone acetate on coagulative and fibrinolytic factors in patients with gynecological cancers].
    Ishizaki T; Itoh R; Yasuda J; Yamamoto T; Okada H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):837-42. PubMed ID: 1534983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coagulation and fibrinolysis in pregnancy].
    Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
    Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia.
    Barton MH; Morris DD; Norton N; Prasse KW
    J Vet Intern Med; 1998; 12(1):26-35. PubMed ID: 9503357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coagulation and anticoagulation systems in newborns--correlation with their mothers at delivery. Lower levels of anticoagulants and fibrinolytic activity in the newborn.
    Lao TT; Yin JA; Yuen PM
    Gynecol Obstet Invest; 1990; 29(3):181-4. PubMed ID: 2141583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of porcine plasmin on the coagulation and fibrinolytic systems in humans.
    Hedner U; Johansson L; Nilsson IM
    Blood; 1978 Jan; 51(1):157-64. PubMed ID: 73391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep venous thrombosis of the arm: a study of coagulation and fibrinolysis.
    Sundqvist SB; Hedner U; Kullenberg HK; Bergentz SE
    Br Med J (Clin Res Ed); 1981 Jul; 283(6286):265-7. PubMed ID: 6788281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand's factor.
    Stead NW; Bauer KA; Kinney TR; Lewis JG; Campbell EE; Shifman MA; Rosenberg RD; Pizzo SV
    Am J Med; 1983 Jan; 74(1):33-9. PubMed ID: 6401391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer.
    von Tempelhoff GF; Dietrich M; Hommel G; Heilmann L
    J Clin Oncol; 1996 Sep; 14(9):2560-8. PubMed ID: 8823336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in blood coagulation and fibrinolysis in the normal puerperium.
    Dahlman T; Hellgren M; Blombäck M
    Gynecol Obstet Invest; 1985; 20(1):37-44. PubMed ID: 3930349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
    Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
    Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.